491.35

-1.14%↓

SANES

8.313

+0.48%↑

SAF

280.3

+0.14%↑

BBVA

15.935

+0.85%↑

BNP

77.86

+1.37%↑

491.35

-1.14%↓

SANES

8.313

+0.48%↑

SAF

280.3

+0.14%↑

BBVA

15.935

+0.85%↑

BNP

77.86

+1.37%↑

491.35

-1.14%↓

SANES

8.313

+0.48%↑

SAF

280.3

+0.14%↑

BBVA

15.935

+0.85%↑

BNP

77.86

+1.37%↑

491.35

-1.14%↓

SANES

8.313

+0.48%↑

SAF

280.3

+0.14%↑

BBVA

15.935

+0.85%↑

BNP

77.86

+1.37%↑

491.35

-1.14%↓

SANES

8.313

+0.48%↑

SAF

280.3

+0.14%↑

BBVA

15.935

+0.85%↑

BNP

77.86

+1.37%↑

Home・Aktien・Gimv NV

Gimv NV

Geschlossen

BrancheFinanzen

45.4 -0.44

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

45.3

Max

45.9

Schlüsselkennzahlen
By Trading Economics
Einkommen	145M
Verkäufe	-74M 114M
KGV Branchendurchschnitt	5.917 27.32
EPS	2.43
Dividendenrendite	5.9
Gewinnspanne	722.337
Angestellte	94
EBITDA	-70M 76M

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	5.90% 3.64%
Nächstes Ergebnis	20. Nov. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	18M 1.6B
Vorheriger Eröffnungskurs	45.84
Vorheriger Schlusskurs	45.4

Nachrichtenstimmung

By Acuity

50%

214 / 531 Ranking in Finance

Gimv NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Gimv NV Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Gimv NV – Dist abgegeben haben.

Stimmung

By Acuity

214 / 531 Ranking in Finanzen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c